Supriya Lifescience has informed that Kedar Karmarkar (Din No.:06499019) and Bhairav Chokshi (Din No.:03612527), Independent Directors of the Company, has completed their 2 terms of 5 years as Independent Directors on February 1, 2025 and accordingly they will cease to be Directors and Independent Directors of the Company with effect from February 1, 2025. In continuation of Outcome of the Board Meeting dated January 24, 2025, filed on January 24, 2025, the company has informed that Dr. Ganapati Dadasaheb Yadav (DIN: 02235661) and Dr. Sunil Subhash Bhagwat (DIN: 10178976) were appointed as an Additional Directors - Non-Executive, Independent Category, with effect from January 24, 2025. Details as required to be disclosed as per the LODR Regulations read with SEBI’s Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023, and Circular No. SEBI/HO/CFD/ CFD-PoD1/P/CIR/2023/123 dated July 13, 2023, are enclosed as Annexure – A.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1609.90 |
Dr. Reddys Lab | 1132.80 |
Cipla | 1458.65 |
Lupin | 2028.90 |
Zydus Lifesciences | 901.15 |
View more.. |